NEWS CENTER
The company completed the B1 round of 50 million financing
2022-06-27
Enzyme Bioengineering Co., Ltd. obtained RMB 50 million B1 from Weifang Zhongke Haichuang Equity Investment Partnership, Tibet Leimei Ruisi Venture Capital and Ningbo Caozhixing Junbo Equity Investment Partnership (reinvestment from the original investor Saisheng Capital). round of financing. Probe Capital acted as financial advisor for this financing. This round of financing will be mainly used to promote the industrialization of cooperative products and enhance the R&D capabilities of the BioEngine® platform.
Enzyme Bioengineering Co., Ltd. obtained RMB 50 million B1 from Weifang Zhongke Haichuang Equity Investment Partnership, Tibet Leimei Ruisi Venture Capital and Ningbo Caozhixing Junbo Equity Investment Partnership (reinvestment from the original investor Saisheng Capital). round of financing. Probe Capital acted as financial advisor for this financing. This round of financing will be mainly used to promote the industrialization of cooperative products and enhance the R&D capabilities of the BioEngine® platform.
Other relevant news
Come visit our booth at Chemspec Europe or CPhI North America!
2022-05-19 22:42
Finally after a long break for many exhibitions, most events are returning onsite and we are looking for to seeing and connecting with you at our booth during the following events:
Learn moreEnzymaster Completed Series B-1 Financing Round
2022-05-19 22:41
Enzymaster, a global biotech company with locations in China, Germany and Singapore specialized in biocatalysis and enzyme engineering, announced the close of a US$ 7.5 Mio (CNY 50 Mio) Series B-1 funding.
Learn moreEnzymaster presenting at Enzyme Engineering XXVI
2022-05-19 22:40
After two years of disruption the Enzyme Engineering XXVI conference focussing on the evolving and expanding uses of enzymes and enzyme engineering in emerging areas will take place in Dallas/Fort Worth, Texas, from May 22nd-27th! Enzymaster has been given the opportunity to present their latest research during this conference on the topic ‘In silico Screening of Transaminase Using Semi-Empirical QM/MM Approach’!
Learn more
Nourishment(Miao Fei)
(Neal.Chen)
